This is an update to the May 27 post: "Sarepta Due for Rebound."Take Profits in Sarepta Therapeutics (SRPT) Sarepta’s solid quarterly report on sales of its Exondys 51 took the market by surprise. The stock jumped to correct the undervaluation. Insiders promptly sold shares: Ticker Owner Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4 SRPT Mahatme Sandesh EVP, CFO & CBO 20-Jul Option Exercise 15.38 50,000 769,107 65,359 ######## SRPT Mahatme Sandesh EVP, CFO & CBO 21-Jul Option Exercise 23.85 1,500 35,775 33,861 ######## SRPT Mahatme Sandesh EVP, CFO & CBO 20-Jul Sale 41 50,000 2,050,000 32,361 ######## SRPT Kaye Edward M. MD Director 20-Jul Sale 41 10,000 410,000 52,471 ######## SRPT Ruff Shamim SVP, Regulatory Affairs & Qual 21-Jul Option Exercise 14.12 5,888 83,133 25,450 ######## SRPT Ruff Shamim SVP, Regulatory Affairs & Qual 20-Jul Option Exercise 13.71 6,250 85,688 27,312 ######## SRPT Ruff Shamim SVP, Regulatory Affairs & Qual 20-Jul Sale 42 6,250 262,500 21,062 ######## SRPT Ruff Shamim SVP, Regulatory Affairs & Qual 21-Jul Sale 44 4,388 193,072 21,062 ######## SRPT Howton David T SVP, General Counsel 21-Jul Option Exercise 20.56 1,000 20,565 23,301 ######## SRPT Howton David T SVP, General Counsel 20-Jul Option Exercise 13.71 25,000 342,750 41,357 ######## SRPT Howton David T SVP, General Counsel 20-Jul Sale 41 25,000 1,025,000 22,301 ######## Total 5,277,590 Remember, value stock members: insiders know more than the individual investor. Time to take some profits off the table. If SRPT stock dips after the U.S. government failed to repeal Obamacare, that is the time to buy the stock. SRPT jumps from $33 to $43: $SRPT, Sarepta Therapeutics, Inc. / H1 HZNP: $HZNP, Horizon Therapeutics Public Limited Company / H1 Related: EXAS (Exact Sciences) is a past top biotech monthly pick. Acadia (ACAD) is an under-valued pick Horizons (HZNP) is a value play whose stock rallied in recent days. Exelixis (EXEL) is on the watch list. * * *Take profits in SRPT. Agree or disagree? Sign in via StockTwits, Facebook, or Twitter to vote. “Like” this post.